Methods of treating mycobacterial infections using tetracycline compounds
EP3774723A1
Process for making sarecycline hydrochloride
MX2019005070A
9-aminomethyl minocycline compounds and use thereof in treating community-acquired bacterial pneumonia (cabp).
TW201808307A
9-aminomethyl minocycline compounds and uses thereof
MX2018013271A
9-aminomethyl minocycline compounds and methods of use thereof in urinary tract infection (uti) treatment.
CN109152789A
Method for treating and preventing clostridium difficile infection
CA2980727A1
Minocycline compounds for biodefense
US2015174144A1
Tetracycline compounds for treating neurodegenerative disorders
AU2013267397A1
7-disubstituted-phenyl tetracycline derivatives
WO2013173326A1
Methods of using (4s,4as,5ar,12as)-4- dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide
HUE044536T2
Crystalline salts of (4s,4as,5ar,12as)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide and methods of using the same
TN2010000539A1
Salts and polymorphs of a tetracylcline compound
TN2010000445A1
Oral and injectable formulations of tetracycline compounds
JO2989B1
Salts and Polymorphs of a Tetracycline Compound
US2010227850A1
Methods for preventing and treating microbial infections by modulating transcription factors
CN102215681A
Tetracycline compounds for the treatment of rheumatoid arthritis and related methods of treatment
TW201741281A
Tosylate salts and polymorphs of a tetracycline compound
